ImmunoBrain, a clinical-stage biopharmaceutical company developing novel immunotherapies for neurodegenerative diseases, today presented new data from the first clinical study in Alzheimer's disease ...

Exam results spanning 13 years are to be analysed by the organisation that sets the assessments after it was revealed that ...

Their call to Congress came a day after President Donald Trump asked TSA agents to show up for their jobs while thanking them ...

Pelareorep treatment drives coordinated immune activation and tertiary lymphoid structure formation Translational data suggest potential to boost ...

Key takeawaysResearchers and scientists have engineered a new class of supercharged T cells that are stronger, longer-lasting ...

Under pressure from President Trump, the House and the far right, Senate Republicans opened debate on Tuesday on legislation ...

From golden images to agent governance, Chainguard Assemble 2026 focused on how teams can reduce risk by embedding trust, ...

UCLA and Stanford Medicine researchers, in collaboration with scientists from the University of Utah and Columbia University, have engineered a new ...

In this Q&A, you will learn about some of the technologies and techniques that are making it possible to address advanced ...

Checkpoint transforms audits, inspections and walkthroughs into connected digital workflows that verify completion and ...

According to the American Lung Association, the national five-year lung cancer survival rate is about 29.7 percent. The ...

A metabolic enzyme studied for over seven decades has a hidden second function—it can unwind RNA and promote cell cycle progression, an additional function beyond its role in energy production, ...